Metabolic syndrome associated with toenail onychomycosis in Taiwanese with diabetes mellitus

International Journal of Dermatology

Volumn 47, Issue 5, 2008, Pages 467-472

  Chang, Shun Jen ^a,b   Hsu, Shih Chieh ^a,b   Tien, Kai Jen ^a,b   Hsiao, Jeng Yueh ^a   Lin, Shiu Ru ^a   Chen, Hung Chun ^a   Hsieh, Ming Chia ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TAIWAN; TOENAIL ONYCHOMYCOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTRIGLYCERIDEMIA; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ONYCHOMYCOSIS; PREVALENCE; RISK FACTORS; SEX FACTORS; TAIWAN; TRIGLYCERIDES;

EID: 42449155491     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03606.x     Document Type: Article

References (38)

1. Chen KT, Chen CJ, Gregg EW, et al. Prevalence of type 2 diabetes mellitus in Taiwan: Ethnic variation and risk factors. Diabetes Res Clin Pract 2001; 51: 59-66.
2. Chou P, Li CL, Tsai ST. Epidemiology of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 2001; 54 (Suppl. 1): S29-S35.
3. Gupta AK, Humke S. The prevalence and management of onychomycosis in diabetic patients. Eur J Dermatol 2000; 10: 379-384.
4. Karchmer AW, Gibbons GW. Foot infections in diabetes: Evaluation and management. Curr Clin Top Infect Dis 1994; 14: 1-22.
5. Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1994; 30: 519-531; quiz 532-514.
6. Rich P. Onychomycosis and tinea pedis in patients with diabetes. J Am Acad Dermatol 2000; 43: S130-S134.
7. Bild DE, Selby JV, Sinnock P, et al. Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care 1989; 12: 24-31.
8. Chiritescu MM, Chiritescu ME, Scher RK. Newer systemic antifungal drugs for the treatment of onychomycosis. Clin Podiatr Med Surg 1996;13: 741-758.
9. Andre J, Achten G. Onychomycosis. Int J Dermatol 1987; 26: 481-490.
10. Albreski DA, Gupta AK, Gross EG. Onychomycosis in diabetes. Management considerations. Postgrad Med 1999: Spec No: 26-30.
11. Gupta AK, Konnikov N, MacDonald P, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: A multicentre survey. Br J Dermatol 1998; 139: 665-671.
12. Levy LA. Epidemiology of onychomycosis in special-risk populations. J Am Podiatr Med Assoc 1997; 87: 546-550.
13. Drake LA, Patrick DL, Fleckman P, et al. The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999; 41: 189-196.
14. Elewski BE, Scher RK, Aly R, et al. Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis. Cutis 1997; 59: 217-220.
15. Dogra S, Kumar B, Bhansali A, et al. Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol 2002; 41: 647-651.
16. Perea S, Ramos MJ, Garau M, et al. Prevalence and risk factors of tinea unguium and tinea pedis in the general population in Spain. J Clin Microbiol 2000; 38: 3226-3230.
17. World Health Organization (WHO). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999.
18. Elewski BE. Diagnostic techniques for confirming onychomycosis. J Am Acad Dermatol 1996; 35: S6-S9.
19. Tom CM, Kane MP. Management of toenail onychomycosis. Am J Health Syst Pharm 1999; 56: 865-871.
20. Gupta AK, Einarson TR, Summerbell RC, et al. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs 1998; 55: 645-674.
21. Evans SL, Nixon BP, Lee I, et al. The prevalence and nature of podiatric problems in elderly diabetic patients. J Am Geriatr Soc 1991; 39: 241-245.
22. Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J Am Acad Dermatol 1992; 26: 408-410.
23. Pierard GE, Pierard-Franchimont C. The nail under fungal siege in patients with type II diabetes mellitus. Mycoses 2005; 48: 339-342.
24. Buren J, Lindmark S, Renstrom F, et al. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: Is cellular insulin resistance caused by glucotoxicity in vivo? Metabolism 2003; 52: 239-245.
25. Tan KC, Tso AW, Ma OC, et al. Determinants of postprandial triglyceride and remnant-like lipoproteins in type 2 diabetes. Diabetes Metab Res Rev 2005; 21: 209-214.
26. Ferrannini E, Haffner SM, Mitchell BD, et al. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
27. Grundy SM. Metabolic syndrome. connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006; 47: 1093-1100.
28. Walrand S, Guillet C, Boirie Y, et al. In vivo evidence that insulin regulates human polymorphonuclear neutrophil functions. J Leukoc Biol 2004; 76: 1104-1110.
29. Sowers JR. Diabetes in the elderly and in women: Cardiovascular risks. Cardiol Clin 2004; 22: 541-551.
30. Grant RW, Meigs JB. Should the insulin resistance syndrome be treated in the elderly? Drugs Aging 2004; 21: 141-151.
31. Wilson RM, Reeves WG. Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin Exp Immunol 1986; 63: 478-484.
32. Rigopoulos D, Katsiboulas V, Koumantaki E, et al. Epidemiology of onychomycosis in southern Greece. Int J Dermatol 1998; 37: 925-928.
33. Chi CC, Wang SH, Chou MC. The causative pathogens of onychomycosis in southern Taiwan. Mycoses 2005; 48: 413-420.
34. Gianni C, Morelli V, Cerri A, et al. Usefulness of histological examination for the diagnosis of onychomycosis. Dermatology 2001; 202: 283-288.
35. Weinberg JM, Koestenblatt EK, Tutrone WD, et al. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol 2003; 49: 193-197.
36. Arnold B, Kianifard F, Tavakkol A. A comparison of KOH and culture results from two mycology laboratories for the diagnosis of onychomycosis during a randomized, multicenter clinical trial: A subset study. J Am Podiatr Med Assoc 2005; 95: 421-423; author reply 423-424.
37. Machler BC, Kirsner RS, Elgart GW. Routine histologic examination for the diagnosis of onychomycosis: An evaluation of sensitivity and specificity. Cutis 1998; 61: 217-219.
38. Lilly KK, Koshnick RL, Grill JP, et al. Cost-effectiveness of diagnostic tests for toenail onychomycosis: A repeated-measure, single-blinded, cross-sectional evaluation of 7 diagnostic tests. J Am Acad Dermatol 2006; 55: 620-626.